TRACON Pharmaceuticals, Inc. Depreciation and Amortization Expense
TRACON Pharmaceuticals, Inc. reported Depreciation and Amortization Expense of $14.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2024-03-05
- TRACON Pharmaceuticals, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2023 was $14.00M, a 12.50% decline from fiscal 2022.
- TRACON Pharmaceuticals, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2022 was $16.00M, a 14.29% increase from fiscal 2021.
- TRACON Pharmaceuticals, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2021 was $14.00M.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|
| 2023-12-31 | $14.00M 10-K · filed 2024-03-05 |
| 2022-12-31 | $16.00M 10-K · filed 2024-03-05 |
| 2021-12-31 | $14.00M 10-K · filed 2024-03-05 |